TRINITY BIOTECH PLC Research and Development Expense
TRINITY BIOTECH PLC (TRIB) reported Research and Development Expense of $4.54 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-05-16.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2025-05-16
- TRINITY BIOTECH PLC research and development expense for the quarter ending 2018-06-30 was $1.42M, a 7.34% increase year-over-year.
- TRINITY BIOTECH PLC research and development expense for the quarter ending 2017-06-30 was $1.32M.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|---|
| 2024-12-31 | $4.54M 20-F · filed 2025-05-16 | ||
| 2024-06-30 | $2.08M 6-K · filed 2024-10-02 | ||
| 2023-12-31 | $4.38M 20-F · filed 2025-05-16 | ||
| 2023-06-30 | $2.09M 6-K · filed 2024-10-02 | ||
| 2022-12-31 | $4.14M 20-F · filed 2025-05-16 | ||
| 2022-06-30 | $1.95M 6-K · filed 2022-11-15 | ||
| 2021-12-31 | $4.50M 20-F · filed 2024-04-30 | ||
| 2021-06-30 | $2.49M 6-K · filed 2022-11-15 | ||
| 2020-12-31 | $5.08M 20-F · filed 2023-05-16 | ||
| 2019-12-31 | $5.33M 20-F · filed 2022-05-02 | ||
| 2018-12-31 | $5.37M 20-F · filed 2021-04-30 | ||
| 2018-06-30 | $1.42M 6-K · filed 2018-07-23 | $2.69M 6-K · filed 2018-07-23 | |
| 2017-12-31 | $5.66M 20-F · filed 2020-06-15 | ||
| 2017-06-30 | $1.32M 6-K · filed 2018-07-23 | $2.65M 6-K · filed 2018-07-23 | |
| 2016-12-31 | $5.04M 20-F · filed 2019-05-14 | ||
| 2015-12-31 | $5.07M 20-F · filed 2018-04-20 |